Oku Digital Health launches platform linking eye-care data to drug development Oku Digital Health has launched a digital health platform connecting more than 10,000 point-of-care locations with pharma...
Overview The News Click Therapeutics has received FDA 510(k) clearance for Motivista (CT-155), a smartphone-based prescription digital therapeutic indicated for treating negative symptoms of schizophr...
Overview The News Click Therapeutics and Boehringer Ingelheim have announced a strategic agreement under which Boehringer will transfer full commercial responsibility and marketing authori...
Overview The News Ultrahuman and Click Therapeutics have partnered to develop Migraine PowerPlug, a software-based feature within the Ultrahuman platform that combines wearable biomar...
